Retraction Note: Thrombin stimulates VSMC proliferation through an EGFR-dependent pathway: involvement of MMP-2 (Molecular and Cellular Biochemistry, (2014), 396, 1-2, (147-160), 10.1007/s11010-014-2151-y);Thrombin stimulates VSMC proliferation through an EGFR-dependent pathway: Involvement of MMP-2

Molecular and Cellular Biochemistry

Volumn 396, Issue 1-2, 2014, Pages 147-160

  Smiljanic, Katarina ^a   Obradovic, Milan ^b   Jovanovic, Aleksandra ^b   Djordjevic, Jelena ^c   Dobutovic, Branislava ^b   Jevremovic, Danimir ^d   Marche, Pierre ^e   Isenovic, Esma R ^b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

^d University Business Academy   (Serbia)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Atherosclerosis; EGFR transactivation; Heparin binding epidermal growth factor like; Matrix metalloproteinase; MMP 2; Pathological VSMC proliferation; Thrombin signaling cascade

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; ACRYLAMIDE DERIVATIVE; EGFR PROTEIN, RAT; EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE A; MITOGEN ACTIVATED PROTEIN KINASE 3; N-(4-(3-BROMOPHENYLAMINO)-7-(3-(4-MORPHOLINYL)PROPOXY)-6-QUINAZOLINYL)-2-PROPENAMIDE; QUINAZOLINE DERIVATIVE; THROMBIN; TYRPHOSTIN;

ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECTS; METABOLISM; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; WISTAR RAT;

ACRYLAMIDES; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 2; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHOSPHORYLATION; QUINAZOLINES; RATS, WISTAR; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; THROMBIN; TYRPHOSTINS;

EID: 84907593049     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-024-05016-x     Document Type: Erratum

References (67)

1. Beckman JA, Creager MA, Libby P (2002) Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 287(19):2570-2581
2. Mnjoyan ZH, Doan D, Brandon JL, Felix K, Sitter CL, Rege AA, Brock TA, Fujise K (2008) The critical role of the intrinsic VSMC proliferation and death programs in injury-induced neointimal hyperplasia. Am J Physiol Heart Circ Physiol 294(5):H2276-H2284. doi: 10.1152/ajpheart.91527.2007
3. Hozawa A, Folsom AR, Sharrett AR, Chambless LE (2007) Absolute and attributable risks of cardiovascular disease incidence in relation to optimal and borderline risk factors: comparison of African American with white subjects - Atherosclerosis Risk in Communities Study. Arch Intern Med 167(6):573-579. doi: 10.1001/archinte.167.6.573
4. Borissoff JI, Spronk HM, Heeneman S, ten Cate H (2009) Is thrombin a key player in the 'coagulation-atherogenesis' maze? Cardiovasc Res 82(3):392-403. doi: 10.1093/cvr/cvp066
5. Smiljanic K, Dobutovic B, Obradovic M, Nikolic D, Marche P, Isenovic ER (2011) Involvement of the ADAM 12 in thrombin-induced rat's VSMCs proliferation. Curr Med Chem 18(22):3382-3386
6. Bobe R, Yin X, Roussanne MC, Stepien O, Polidano E, Faverdin C, Marche P (2003) Evidence for ERK1/2 activation by thrombin that is independent of EGFR transactivation. Am J Physiol Heart Circ Physiol 285(2):H745-H754. doi: 10.1152/ajpheart.01042.2002
7. Hsieh HL, Tung WH, Wu CY, Wang HH, Lin CC, Wang TS, Yang CM (2009) Thrombin induces EGF receptor expression and cell proliferation via a PKC(delta)/c-Src-dependent pathway in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 29(10):1594-1601. doi: 10.1161/ATVBAHA.109.185801
8. Prenzel N, Zwick E, Daub H, Leserer M, Abraham R, Wallasch C, Ullrich A (1999) EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402(6764):884-888. doi: 10.1038/47260
9. Isenovic ER, Kedees MH, Haidara MA, Trpkovic A, Mikhailidis DP, Marche P (2010) Involvement of ERK1/2 kinase in insulin-and thrombin-stimulated vascular smooth muscle cell proliferation. Angiology 61(4):357-364. doi: 10.1177/0003319709358693
10. Kalmes A, Vesti BR, Daum G, Abraham JA, Clowes AW (2000) Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor. Circ Res 87(2):92-98. doi: 10.1161/01.RES.87.2.92
11. Hsieh HL, Sun CC, Wang TS, Yang CM (2008) PKC-delta/c-Src-mediated EGF receptor transactivation regulates thrombin-induced COX-2 expression and PGE(2) production in rat vascular smooth muscle cells. Biochim Biophys Acta 1783(9):1563-1575. doi: 10.1016/j.bbamcr.2008.03.016
12. Yin X, Polidano E, Faverdin C, Marche P (2005) Role of L-type calcium channel blocking in epidermal growth factor receptor-independent activation of extracellular signal regulated kinase 1/2. J Hypertens 23(2):337-350
13. Wang H, Ubl JJ, Stricker R, Reiser G (2002) Thrombin (PAR-1)-induced proliferation in astrocytes via MAPK involves multiple signaling pathways. Am J Physiol Cell Physiol 283(5):C1351-C1364. doi: 10.1152/ajpcell.00001.2002
14. Huang YL, Shi GY, Lee H, Jiang MJ, Huang BM, Wu HL, Yang HY (2009) Thrombin induces nestin expression via the transactivation of EGFR signalings in rat vascular smooth muscle cells. Cell Signal 21(6):954-968. doi: 10.1016/j.cellsig.2009.02.005
15. Koo BH, Han JH, Yeom YI, Kim DS (2010) Thrombin-dependent MMP-2 activity is regulated by heparan sulfate. J Biol Chem 285(53):41270-41279. doi: 10.1074/jbc.M110.171595
16. Newby AC (2006) Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates. Cardiovasc Res 69(3):614-624. doi: 10.1016/j.cardiores.2005.08.002
17. Ohtsu H, Dempsey PJ, Eguchi S (2006) ADAMs as mediators of EGF receptor transactivation by G protein-coupled receptors. Am J Physiol Cell Physiol 291(1):C1-C10. doi: 10.1152/ajpcell.00620.2005
18. Doran AC, Meller N, McNamara CA (2008) Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol 28(5):812-819. doi: 10.1161/ATVBAHA.107.159327
19. Hayashi K, Naiki T (2009) Adaptation and remodeling of vascular wall; biomechanical response to hypertension. J Mech Behav Biomed Mater 2(1):3-19. doi: 10.1016/j.jmbbm.2008.05.002
20. Sata M (2003) Circulating vascular progenitor cells contribute to vascular repair, remodeling, and lesion formation. Trends Cardiovasc Med 13(6):249-253
21. McNamara CA, Sarembock IJ, Bachhuber BG, Stouffer GA, Ragosta M, Barry W, Gimple LW, Powers ER, Owens GK (1996) Thrombin and vascular smooth muscle cell proliferation: implications for atherosclerosis and restenosis. Semin Thromb Hemost 22(2):139-144. doi: 10.1055/s-2007-999001
22. Isenovic E, Muniyappa R, Milivojevic N, Rao Y, Sowers JR (2001) Role of PI3-kinase in isoproterenol and IGF-1 induced ecNOS activity. Biochem Biophys Res Commun 285(4):954-958. doi: 10.1006/bbrc.2001.5246
23. Blendea MC, McFarlane SI, Isenovic ER, Gick G, Sowers JR (2003) Heart disease in diabetic patients. Curr Diabetes Rep 3(3):223-229. doi: 10.1007/s11892-003-0068-z
24. Ross R (1971) The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers. J Cell Biol 50(1):172-186. doi: 10.1083/jcb.50.1.172
25. Marche P, Herembert T, Zhu DL (1995) Molecular mechanisms of vascular hypertrophy in the spontaneously hypertensive rat. Clin Exp Pharmacol Physiol Suppl 22(1):S114-S116. doi: 10.1111/j.1440-1681.1995.tb02844.x
26. Standley PR, Zhang F, Ram JL, Zemel MB, Sowers JR (1991) Insulin attenuates vasopressin-induced calcium transients and a voltage-dependent calcium response in rat vascular smooth muscle cells. J Clin Investig 88(4):1230-1236. doi: 10.1172/JCI115426
27. Isenovic ER, Fretaud M, Koricanac G, Sudar E, Velebit J, Dobutovic B, Marche P (2009) Insulin regulation of proliferation involves activation of AKT and ERK 1/2 signaling pathways in vascular smooth muscle cells. Exp Clin Endocrinol Diabetes 117(5):214-219. doi: 10.1055/s-0028-1085470
28. Isenovic ER, Jacobs DB, Kedees MH, Sha Q, Milivojevic N, Kawakami K, Gick G, Sowers JR (2004) Angiotensin II regulation of the Na+ pump involves the phosphatidylinositol-3 kinase and p42/44 mitogen-activated protein kinase signaling pathways in vascular smooth muscle cells. Endocrinology 145(3):1151-1160. doi: 10.1210/en.2003-0100
29. Burnette WN (1981) "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem 112(2):195-203. doi: 10.1016/0003-2697(81)90281-5
30. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227(5259):680-685. doi: 10.1038/227680a0
31. Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76(9):4350-4354. doi: 10.1073/pnas.76.9.4350
32. Stepien O, Gogusev J, Zhu DL, Iouzalen L, Herembert T, Drueke TB, Marche P (1998) Amlodipine inhibition of serum-, thrombin-, or fibroblast growth factor-induced vascular smooth-muscle cell proliferation. J Cardiovasc Pharmacol 31(5):786-793
33. Smaill JB, Rewcastle GW, Loo JA, Greis KD, Chan OH, Reyner EL, Lipka E, Showalter HD, Vincent PW, Elliott WL, Denny WA (2000) Tyrosine kinase inhibitors. 17. Irreversible inhibitors of the epidermal growth factor receptor: 4-(phenylamino)quinazoline- and 4-(phenylamino)pyrido[3,2-d]pyrimidine-6-acrylamides bearing additional solubilizing functions. J Med Chem 43(7):1380-1397. doi: 10.1021/jm990482t
34. Daub H, Weiss FU, Wallasch C, Ullrich A (1996) Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 379(6565):557-560. doi: 10.1038/379557a0
35. Stix B, Kahne T, Sletten K, Raynes J, Roessner A, Rocken C (2001) Proteolysis of AA amyloid fibril proteins by matrix metalloproteinases-1, -2, and -3. Am J Pathol 159(2):561-570. doi: 10.1016/S0002-9440(10)61727-0
36. Nishino N, Powers JC (1978) Peptide hydroxamic acids as inhibitors of thermolysin. Biochemistry 17(14):2846-2850. doi: 10.1021/bi00607a023
37. Levitzki A, Gazit A (1995) Tyrosine kinase inhibition: an approach to drug development. Science 267(5205):1782-1788. doi: 10.1126/science.7892601
38. Osherov N, Levitzki A (1994) Epidermal-growth-factor-dependent activation of the src-family kinases. European J Biochem/FEBS 225(3):1047-1053. doi: 10.1111/j.1432-1033.1994.1047b.x
39. Kanda Y, Mizuno K, Kuroki Y, Watanabe Y (2001) Thrombin-induced p38 mitogen-activated protein kinase activation is mediated by epidermal growth factor receptor transactivation pathway. Br J Pharmacol 132(8):1657-1664. doi: 10.1038/sj.bjp.0703952
40. Reynolds CM, Eguchi S, Frank GD, Motley ED (2002) Signaling mechanisms of heparin-binding epidermal growth factor-like growth factor in vascular smooth muscle cells. Hypertension 39(2 Pt 2):525-529. doi: 10.1161/hy0202.103076
41. Isenovic ER, Soskic S, Trpkovic A, Dobutovic B, Popovic M, Gluvic Z, Putnikovic B, Marche P (2010) Insulin, thrombine, ERK1/2 kinase and vascular smooth muscle cells proliferation. Curr Pharm Des 16(35):3895-3902
42. Meloche S, Pouyssegur J (2007) The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene 26(22):3227-3239. doi: 10.1038/sj.onc.1210414
43. Ginnan R, Pfleiderer PJ, Pumiglia K, Singer HA (2004) PKC-delta and CaMKII-delta 2 mediate ATP-dependent activation of ERK1/2 in vascular smooth muscle. Am J Physiol Cell Physiol 286(6):C1281-C1289. doi: 10.1152/ajpcell.00202.2003
44. Dreux AC, Lamb DJ, Modjtahedi H, Ferns GA (2006) The epidermal growth factor receptors and their family of ligands: their putative role in atherogenesis. Atherosclerosis 186(1):38-53. doi: 10.1016/j.atherosclerosis.2005.06.038
45. Seals DF, Courtneidge SA (2003) The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev 17(1):7-30. doi: 10.1101/gad.1039703
46. Uzui H, Lee JD, Shimizu H, Tsutani H, Ueda T (2000) The role of protein-tyrosine phosphorylation and gelatinase production in the migration and proliferation of smooth muscle cells. Atherosclerosis 149(1):51-59
47. McCarty RE (1992) Iron contamination in adenosine triphosphate: a warning. Anal Biochem 205(2):371-372. doi: 10.1016/0003-2697(92)90452-D
48. Moon SK, Jung SY, Choi YH, Lee YC, Patterson C, Kim CH (2004) PDTC, metal chelating compound, induces G1 phase cell cycle arrest in vascular smooth muscle cells through inducing p21Cip1 expression: involvement of p38 mitogen activated protein kinase. J Cell Physiol 198(2):310-323. doi: 10.1002/jcp.10728
49. Ichiki T, Tokunou T, Fukuyama K, Iino N, Masuda S, Takeshita A (2004) 15-Deoxy-delta12,14-prostaglandin J2 and thiazolidinediones transactivate epidermal growth factor and platelet-derived growth factor receptors in vascular smooth muscle cells. Biochem Biophys Res Commun 323(2):402-408. doi: 10.1016/j.bbrc.2004.08.101
50. Shah BH, Yesilkaya A, Olivares-Reyes JA, Chen HD, Hunyady L, Catt KJ (2004) Differential pathways of angiotensin II-induced extracellularly regulated kinase 1/2 phosphorylation in specific cell types: role of heparin-binding epidermal growth factor. Mol Endocrinol 18(8):2035-2048. doi: 10.1210/me.2003-0476
51. Zhang H, Chalothorn D, Jackson LF, Lee DC, Faber JE (2004) Transactivation of epidermal growth factor receptor mediates catecholamine-induced growth of vascular smooth muscle. Circ Res 95(10):989-997. doi: 10.1161/01.RES.0000147962.01036.bb
52. Lovdahl C, Thyberg J, Hultgardh-Nilsson A (2000) The synthetic metalloproteinase inhibitor batimastat suppresses injury-induced phosphorylation of MAP kinase ERK1/ERK2 and phenotypic modification of arterial smooth muscle cells in vitro. J Vasc Res 37(5):345-354
53. Uglow EB, Slater S, Sala-Newby GB, Aguilera-Garcia CM, Angelini GD, Newby AC, George SJ (2003) Dismantling of cadherin-mediated cell-cell contacts modulates smooth muscle cell proliferation. Circ Res 92(12):1314-1321. doi: 10.1161/01.RES.0000079027.44309.53
54. Yang CM, Lin MI, Hsieh HL, Sun CC, Ma YH, Hsiao LD (2005) Bradykinin-induced p42/p44 MAPK phosphorylation and cell proliferation via Src, EGF receptors, and PI3-K/Akt in vascular smooth muscle cells. J Cell Physiol 203(3):538-546. doi: 10.1002/jcp.20250
55. Bendeck MP, Irvin C, Reidy MA (1996) Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury. Circ Res 78(1):38-43. doi: 10.1161/01.RES.78.1.38
56. Zempo N, Koyama N, Kenagy RD, Lea HJ, Clowes AW (1996) Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor. Arterioscler Thromb Vasc Biol 16(1):28-33. doi: 10.1161/01.ATV.16.1.28
57. Grantcharova E, Reusch HP, Grossmann S, Eichhorst J, Krell HW, Beyermann M, Rosenthal W, Oksche A (2006) N-terminal proteolysis of the endothelin B receptor abolishes its ability to induce EGF receptor transactivation and contractile protein expression in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 26(6):1288-1296. doi: 10.1161/01.ATV.0000220377.51354.30
58. Hultgardh-Nilsson A, Lovdahl C, Blomgren K, Kallin B, Thyberg J (1997) Expression of phenotype- and proliferation-related genes in rat aortic smooth muscle cells in primary culture. Cardiovasc Res 34(2):418-430
59. Thyberg J (1998) Phenotypic modulation of smooth muscle cells during formation of neointimal thickenings following vascular injury. Histol Histopathol 13(3):871-891. doi: 10.1177/002215549704500608
60. Pauly RR, Passaniti A, Bilato C, Monticone R, Cheng L, Papadopoulos N, Gluzband YA, Smith L, Weinstein C, Lakatta EG et al (1994) Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation. Circ Res 75(1):41-54. doi: 10.1161/01.RES.75.1.41
61. Newby AC, Zaltsman AB (1999) Fibrous cap formation or destruction - the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation. Cardiovasc Res 41(2):345-360
62. Shah PK, Galis ZS (2001) Matrix metalloproteinase hypothesis of plaque rupture: players keep piling up but questions remain. Circulation 104(16):1878-1880. doi: 10.1161/hc4101.097419
63. Southgate KM, Davies M, Booth RF, Newby AC (1992) Involvement of extracellular-matrix-degrading metalloproteinases in rabbit aortic smooth-muscle cell proliferation. Biochem J 288(Pt 1):93-99
64. Islam MM, Franco CD, Courtman DW, Bendeck MP (2003) A nonantibiotic chemically modified tetracycline (CMT-3) inhibits intimal thickening. Am J Pathol 163(4):1557-1566. doi: 10.1016/S0002-9440(10)63512-2
65. Bendeck MP, Conte M, Zhang M, Nili N, Strauss BH, Farwell SM (2002) Doxycycline modulates smooth muscle cell growth, migration, and matrix remodeling after arterial injury. Am J Pathol 160(3):1089-1095. doi: 10.1016/S0002-9440(10)64929-2
66. Ikejiri M, Bernardo MM, Bonfil RD, Toth M, Chang M, Fridman R, Mobashery S (2005) Potent mechanism-based inhibitors for matrix metalloproteinases. J Biol Chem 280(40):33992-34002. doi: 10.1074/jbc.M504303200
67. Mukhin YV, Gooz M, Raymond JR, Garnovskaya MN (2006) Collagenase-2 and -3 mediate epidermal growth factor receptor transactivation by bradykinin B2 receptor in kidney cells. J Pharmacol Exp Ther 318(3):1033-1043. doi: 10.1124/jpet.106.104000